The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

INVEGA 9 mg prolonged-release tablets

Janssen-Cilag International NVEU/1/07/395/11-15

Main Information

Trade NameINVEGA 9 mg prolonged-release tablets
Active SubstancesPaliperidone
Dosage FormProlonged-release tablet
Licence HolderJanssen-Cilag International NV
Licence NumberEU/1/07/395/11-15

Group Information

ATC CodeN05AX Other antipsychotics
N05AX13 paliperidone


License statusAuthorised
Licence Issued25/06/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0130-178-024
Interchangeable List DocumentPDF of Interchangeable List
« Back